Targeting multidrug resistance in cancer

Nature Reviews. Drug Discovery
Gergely SzakácsMichael M Gottesman

Abstract

Effective treatment of metastatic cancers usually requires the use of toxic chemotherapy. In most cases, multiple drugs are used, as resistance to single agents occurs almost universally. For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chemical structures - multidrug resistance - has been a major goal of cancer biologists during the past 35 years. Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters. We describe various approaches to combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters.

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Jan 1, 1992·Annual Review of Cell Biology·C F Higgins
Jan 9, 1992·Biochemical Pharmacology·P R Twentyman
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·J HofmannH Grunicke
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E B Mechetner, I B Roninson
Sep 1, 1990·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·C Cordon-CardoM R Melamed
Jun 5, 1991·Journal of the National Cancer Institute·A MonksA Vaigro-Wolff
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·K UedaI Pastan
Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D J FitzGeraldI Pastan
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·G J ZamanP Borst
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G C WishartR C Leonard
May 1, 1993·British Journal of Cancer·M J MillwardA L Harris
Mar 1, 1996·International Journal of Cancer. Journal International Du Cancer·M D NorrisI B Roninson
Feb 7, 1998·The Journal of Clinical Investigation·R B KimG R Wilkinson
Jun 1, 1997·Seminars in Cancer Biology·A H Schinkel
May 23, 1998·The Journal of Biological Chemistry·T GerloffP J Meier
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D M Bradshaw, R J Arceci
Nov 21, 1998·The Journal of Biological Chemistry·E BakosB Sarkadi
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Jan 15, 1999·Pathology Oncology Research : POR·G SzakácsB Sarkadi
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J KönigD Keppler

❮ Previous
Next ❯

Citations

Mar 14, 2007·Archives of Toxicology·Neil Macdonald, Alex Gledhill
Apr 9, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·Martin WernerMartin Hohenegger
Jul 20, 2007·Cancer Chemotherapy and Pharmacology·Fanying MengCharles P Hart
Jan 22, 2008·Cancer Chemotherapy and Pharmacology·Tomohiro NabekuraShuji Kitagawa
Nov 29, 2008·Cancer Chemotherapy and Pharmacology·Satoru TanakaNobuhiko Tanigawa
Oct 12, 2012·Cancer Chemotherapy and Pharmacology·Nicolay V LitviakovVladimir M Perelmuter
Apr 17, 2013·Cancer Chemotherapy and Pharmacology·Weidong JiaQiaohong Duan
May 16, 2013·Cancer Chemotherapy and Pharmacology·Atish PatelZhe-Sheng Chen
Oct 13, 2007·Journal of Cancer Research and Clinical Oncology·Martina HubensackArmin Buschauer
Mar 3, 2007·Cancer Metastasis Reviews·Yehuda G Assaraf
May 8, 2007·Investigational New Drugs·Gene L BidwellDrazen Raucher
Feb 3, 2012·Journal of Bioenergetics and Biomembranes·Ayako NakanoMasahiro Abe
Feb 14, 2012·Journal of Bioenergetics and Biomembranes·Simone CardaciMaria Rosa Ciriolo
Apr 26, 2013·Journal of Pharmacokinetics and Pharmacodynamics·Susan F Hudachek, Daniel L Gustafson
Aug 20, 2011·Pharmaceutical Research·Zhongxing LiangHyunsuk Shim
Jun 18, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Qing ChenJuan Chen
Apr 25, 2012·Current Treatment Options in Oncology·Carrie Marquette, Lisle Nabell
Jun 11, 2008·Current Neurology and Neuroscience Reports·Jaishri Blakeley
May 26, 2009·Medical Oncology·Malathy P V ShekharDaniel W Visscher
Aug 19, 2010·Molecular Biotechnology·Bruce C Baguley
May 4, 2013·Pathology Oncology Research : POR·Li ZhouPing Liu
Feb 26, 2013·Archives of Pharmacal Research·Seok-Jeong OhMoo-Yeol Lee
May 16, 2013·Archives of Pharmacal Research·Omidreza FiruziRamin Miri
Jun 16, 2012·Journal of Physiology and Biochemistry·Bei-Bei ZhengXiu-Li Guo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

© 2021 Meta ULC. All rights reserved